Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adhesion G protein-coupled receptor G2 (ADGRG2), also known as GPR64, is a member of the adhesion family of G protein-coupled receptors predominantly expressed in the male reproductive tract, especially in the epididymis and efferent ducts[2][3][4]. It plays a critical role in regulating fluid reabsorption and maintaining male fertility by mediating signal transduction via G protein pathways (primarily Gs and Gq), affecting the function of downstream effectors such as adenylate cyclase and phospholipase C[2][3]. Mutations in ADGRG2 are implicated in disorders such as congenital bilateral absence of the vas deferens, leading to male infertility[2][3]. Recent structural studies identified steroid hormones, including DHEA, as ligands, providing the basis for ongoing pharmacological research and making ADGRG2 a potential therapeutic target for male reproductive health and related conditions[1].
Agonist binding (e.g., DHEA) activates G protein signaling via Gs and Gq proteins, leading to stimulation of adenylate cyclase or phospholipase C pathways[1][2][3].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adhesion G protein-coupled receptor G2 (ADGRG2).